Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018405 |
---|---|
Receipt number | R000021307 |
Scientific Title | Prospective Follow-up of Relapse Myeloma Patients after Previous Exposure to Bortezomib and Lenalidomide Treated on Pomalidomide and Dexamethasone |
Date of disclosure of the study information | 2015/08/01 |
Last modified on | 2019/02/25 14:24:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/24 00:05:32 | ||
2 | Update | 2015/07/24 01:20:43 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
3 | Update | 2015/08/04 12:57:44 | Acronym Acronym |
|
4 | Update | 2019/02/25 10:12:27 | Recruitment status Date analysis concluded Publication of results |
|
5 | Update | 2019/02/25 14:24:55 | Last follow-up date Date of closure to data entry Date trial data considered complete |